Literature DB >> 30846366

Amygdala-Hippocampal Connectivity Is Associated With Endogenous Levels of Oxytocin and Can Be Altered by Exogenously Administered Oxytocin in Adults With Autism.

Kaat Alaerts1, Sylvie Bernaerts2, Bart Vanaudenaerde3, Nicky Daniels2, Nicole Wenderoth4.   

Abstract

BACKGROUND: Oxytocin (OT) plays a pivotal role in interpersonal bonding, affiliation, and trust, and its intranasal administration is increasingly considered as a potential treatment for autism spectrum disorder.
METHODS: We explored whether variations in endogenous salivary OT concentration are related to interindividual differences in core autism symptoms and expressions of attachment in 38 male adults with autism spectrum disorder. Further, resting-state functional magnetic resonance imaging was adopted to specifically explore whether interindividual differences are reflected in the intrinsic network organization of key regions of the central oxytocinergic system.
RESULTS: Positive correlations were identified between peripheral OT and expressions of secure attachment (the State Adult Attachment Measure and the Inventory of Peer Attachment), but no significant relationships were identified with scales assessing core autism symptom domains (the Social Responsiveness Scale and the Repetitive Behavior Scale). At the neural level, higher levels of endogenous OT were associated with lower degrees of interregional functional coupling between the amygdala and hippocampal regions. Interestingly, a single dose of exogenously administered OT induced a further reduction in amygdala-hippocampal connectivity, indicating that a higher availability of OT can alter the degree of amygdala-hippocampal connectivity.
CONCLUSIONS: The identified associations between the oxytocinergic system, expressions of secure attachment, and amygdala-hippocampal pathways are anticipated to be of relevance for understanding the role of OT in modulating appropriate neural and physiological responses to stress and restoring homeostasis.
Copyright © 2019 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amygdala; Attachment; Autism spectrum disorders; Hippocampus; Oxytocin; Resting-state fMRI

Mesh:

Substances:

Year:  2019        PMID: 30846366     DOI: 10.1016/j.bpsc.2019.01.008

Source DB:  PubMed          Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging        ISSN: 2451-9022


  15 in total

1.  Plasma oxytocin and vasopressin levels in young and older men and women: Functional relationships with attachment and cognition.

Authors:  Gabriela Plasencia; Joerg M Luedicke; Hossein P Nazarloo; C Sue Carter; Natalie C Ebner
Journal:  Psychoneuroendocrinology       Date:  2019-08-31       Impact factor: 4.905

2.  Association between salivary oxytocin levels and the amygdala and hippocampal volumes.

Authors:  Qiulu Shou; Junko Yamada; Kuniyuki Nishina; Masahiro Matsunaga; Tetsuya Matsuda; Haruto Takagishi
Journal:  Brain Struct Funct       Date:  2022-08-09       Impact factor: 3.748

3.  Social experience alters oxytocinergic modulation in the nucleus accumbens of female prairie voles.

Authors:  Amélie M Borie; Sena Agezo; Parker Lunsford; Arjen J Boender; Ji-Dong Guo; Hong Zhu; Gordon J Berman; Larry J Young; Robert C Liu
Journal:  Curr Biol       Date:  2022-02-01       Impact factor: 10.834

4.  Oxytocin induces long-lasting adaptations within amygdala circuitry in autism: a treatment-mechanism study with randomized placebo-controlled design.

Authors:  Kaat Alaerts; Sylvie Bernaerts; Jellina Prinsen; Claudia Dillen; Jean Steyaert; Nicole Wenderoth
Journal:  Neuropsychopharmacology       Date:  2020-03-11       Impact factor: 8.294

Review 5.  Structural, Functional, and Molecular Imaging of Autism Spectrum Disorder.

Authors:  Xiaoyi Li; Kai Zhang; Xiao He; Jinyun Zhou; Chentao Jin; Lesang Shen; Yuanxue Gao; Mei Tian; Hong Zhang
Journal:  Neurosci Bull       Date:  2021-03-29       Impact factor: 5.271

Review 6.  Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications.

Authors:  Alexandria N Tartt; Madeline B Mariani; Rene Hen; J John Mann; Maura Boldrini
Journal:  Mol Psychiatry       Date:  2022-03-30       Impact factor: 13.437

Review 7.  Anxiolytic and Anxiogenic? How the Transcription Factor MEF2 Might Explain the Manifold Behavioral Effects of Oxytocin.

Authors:  Benjamin Jurek; Magdalena Meyer
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-08       Impact factor: 5.555

Review 8.  The promiscuity of the oxytocin-vasopressin systems and their involvement in autism spectrum disorder.

Authors:  Amelie M Borie; Constantina Theofanopoulou; Elissar Andari
Journal:  Handb Clin Neurol       Date:  2021

9.  Effects of oxytocin administration and conditioned oxytocin on brain activity: An fMRI study.

Authors:  Aleksandrina Skvortsova; Dieuwke S Veldhuijzen; Mischa de Rover; Gustavo Pacheco-Lopez; Marian Bakermans-Kranenburg; Marinus van IJzendoorn; Niels H Chavannes; Henriët van Middendorp; Andrea W M Evers
Journal:  PLoS One       Date:  2020-03-19       Impact factor: 3.240

10.  Myocyte Enhancer Factor 2A (MEF2A) Defines Oxytocin-Induced Morphological Effects and Regulates Mitochondrial Function in Neurons.

Authors:  Magdalena Meyer; Kerstin Kuffner; Julia Winter; Inga D Neumann; Christian H Wetzel; Benjamin Jurek
Journal:  Int J Mol Sci       Date:  2020-03-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.